Life Sciences Times

Seaport Therapeutics Reports $62.6 Million Quarterly Loss, Advances Depression and Anxiety Programs

FDA Grants Orphan Drug Designation to Zai Lab’s Zoci for Neuroendocrine Carcinomas

Obsidian Therapeutics Completes Galera Merger and $350 Million Financing

Korsana Biosciences Expands Leadership Team as Alzheimer’s Program Advances

Dash Bio Raises $30 Million Series A to Speed Drug Development

RecovryAI Completes Patient Phase of Pivotal Clinical AI Trial

Baxter Reports 5% Sales Growth, Raises 2026 Outlook

One Biosciences Validates Single-Cell Tumor Profiling Using Routine Pathology Samples

Meitheal Pharmaceuticals Wins FDA Approval for Garzulys Insulin Biosimilar

Poxel Reports Higher Q2 Revenue, Delays 2025 Financial Statements